ELDN
Eledon Pharmaceuticals Inc
2.70$
-5.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 65.6% | 44.6% | 59.4% | 72.4% | 71.1% | 81.0% | 79.2% | 76.9% | 74.2% | 80.3% | 77.4% | 73.8% | |
| 3.8% | 3.7% | 7.0% | 21.6% | 5.9% | 11.6% | 5.3% | 4.0% | 2.8% | 13.5% | 4.2% | 5.4% | |
| 62.0% | 40.6% | 53.0% | 69.4% | 68.2% | 79.0% | 77.4% | 74.2% | 71.9% | 78.9% | 75.7% | 70.4% | |
| – | – | – | – | – | – | 0.5% | 0.5% | 0.6% | 0.3% | 0.4% | 0.3% | |
| 33.7% | 25.7% | 40.1% | 26.9% | 28.3% | 18.3% | 20.1% | 22.3% | 24.9% | 19.2% | 22.1% | 25.7% | |
| 4.9% | 33.7% | 7.4% | 107.1% | 33.6% | 33.4% | 29.0% | 26.8% | 72.8% | 52.0% | 31.5% | 42.9% | |
| 3.0% | 3.1% | 5.3% | 5.0% | 10.9% | 6.5% | 5.7% | 9.5% | 11.0% | 10.9% | 9.2% | 9.3% | |
| 0.4% | 0.3% | 0.4% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 0.2% | 0.3% | 0.3% | |
| 0.5% | 0.8% | 2.3% | 1.8% | 5.1% | 3.3% | 1.8% | 4.0% | 3.6% | 2.1% | 4.5% | 2.5% | |
| 95.1% | 66.3% | 92.6% | -7.1% | 66.4% | 66.6% | 71.0% | 73.2% | 27.2% | 48.0% | 68.5% | 57.1% | |
| -243.1% | -193.2% | -313.7% | -322.0% | -271.4% | -200.4% | -224.5% | -257.6% | -300.9% | -237.4% | -300.2% | -374.2% | |
| 31.2% | 19.2% | 37.1% | 35.1% | 48.4% | 33.7% | 47.8% | 53.2% | 59.4% | 44.6% | 76.7% | 90.1% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.